Abstract
Recent extensive application of various cell-mediated therapeutic approaches has resulted in increased needs for both specific blood-derived cells and operating procedures to get minimized cell damages during their collection, processing, and storage in liquid or frozen state. The aim of cryoinvestigations is to minimize cell injuries during the freeze/thaw process (cryoinjury). Cryoinjuries may be the result of extensive cell dehydration and/or intracellular ice crystallization. The basic goal of cryopreservation is to maintain the cell viability—which may be defined as the ability of cells to perform their normal or near-normal function when transfused or transplanted. Generally, postthaw cell recovery is superior when the most appropriate freezing procedure and the best cryoprotective agent (cryoprotectant) are used. For blood progenitor or cell cryopreservation, glycerol, dimethyl sulfoxide (DMSO), and hydroxyetilstarch (HES) are regularly used, although in different concentrations. Despite the fact that cell freezing practice is already in routine use, some questions related to the optimal living cell cryopreservation are still unresolved.
“Problems worthy of attack prove their worth by fighting back.”
– Paul Erdos
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balint B, Radovic M (1993) Biophysical aspects of cryopreservation of hematopoietic stem and progenitor cells. Bull Transfus 21:3–8
Meryman HT (2007) Cryopreservation of living cells: principles and practice. Transfusion 47:935–45
Polge C, Smith AU, Parkes AS (1949) Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature 164:666
Barnes DWH, Loutit JF (1955) The radiation recovery factor: preservation by the Polge-Smith-Parkers technique. J Natl Cancer Inst 15:901–906
Lovelock JE, Bishop MWH (1959) Prevention of freezing damage to living cells by dimethyl-sulfoxide. Nature 183:1394–5
Meryman HT (1956) Mechanics of freezing in living cells and tissues. Science 124:515–21
Mazur P (1966) Theoretical and experimental effects of cooling and warming velocity on the survival of frozen and thawed cells. Cryobiology 2:181–92
Lewis JP, Passovoy M, Trobaugh FE (1966) The transplantation efficiency of marrow cooled to −100°C at 2°C per minute. Cryobiology 3:47–52
Litvan GG (1972) Mechanism of cryoinjury in biological systems. Cryobiology 9:181–91
Balint B (2004) Coexistent cryopreservation strategies: microprocessor-restricted vs. uncontrolled-rate freezing of the “blood−derived” progenitors/cells. Blood Banking Transf Med 2(2):62–71
Balint B, Ivanovic Z, Petakov M et al (1999) The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of MRA. Bone Marrow Transplant 23:613–9
Balint B (2003) Blood cell cryopreservation. In: Balint B (ed) Transfusion Medicine. CTCI-Press, Belgrade, pp 479–95
Montanari M, Capelli D, Poloni A et al (2003) Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees C. Transfusion 43:42–9
Lakota J, Fuchsberger P (1996) Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 18:262–3
Rowley SD, Feng Z, Chen L et al (2003) A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 31:1043–51
Hubel A, Carlquist D, Clay M, McCullough J (2004) Liquid storage, shipment, and cryopreservation of cord blood. Transfusion 44:518–25
Liu JH, Ouyang XL, Lu LC, Gao D (2002) Thermometry of intracellular ice crystal formation in cryopreserved platelets. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10(6):574–6
Rowe AW, Rinfret AP (1962) Controlled rate freezing of bone marrow. Blood 20:636
Abrahamsen JF, Bakken AM, Bruserud O (2002) Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 42:1573–80
Balint B, Ivanovic Z, Petakov M et al (1999) Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation. Vojnosanit Pregl 56:577–85
Balint B, Taseski J (2000) Cryopreservation of hematopoietic stem and progenitor cells. Maked Med Pregl 54:80–4
Balint B, Taseski J (1999) Long-term storage of blood cells by cryopreservation. Vojnosanit Pregl 56:157–66
Balint B, Stamatovic D, Todorovic M, Elez M, Vojvodic D, Pavlovic M, Cucuz-Jokic M (2011) Autologous transplant in aplastic anemia: quantity of CD34+/CD90+ subset as the predictor of clinical outcome. Transf Apher Sci 45(2):137–41
Stiff PJ, Koester AR, Weidner MK et al (1987) Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 70:974–8
Clark J, Pati A, McCarthy D (1991) Successful cryopreservation of human bone marrow does not require a controlled-rate freezer. Bone Marrow Transplant 7:121–5
Halle P, Tournilhac O, TournilhacKnopinska-Posluszny W et al (2001) Uncontrolled-rate freezing and storage at −80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 41:667–73
Ahwood-Smith MJ (1961) Preservation of mouse bone marrow at −79°C with dimethyl sulfoxide. Nature 190: 4782, 1204–5
Rowe AW (1966) Biochemical aspects of cryoprotective agents in freezing and thawing. Cryobiology 3:12–8
Meryman HT (1971) Cryoprotective agents. Cryobiology 8:173–83
McGann LE (1978) Differing actions of penetrating and nonpenetrating cryoprotective agents. Cryobiology 15:382–90
Buchanan SS, Gross SA, Acker JP, Toner M, Carpenter JF, Pyatt DW (2004) Cryopreservation of stem cells using trehalose: evaluation of the method using a human hematopoietic cell line. Stem Cells Dev 13:295–305
Gorin NC (1986) Collection, manipulation and freezing of haemopoetic stem cells. Clin Haematol 15:19–48
Moroff G, Seetharaman S, Kurtz JW, Greco NJ, Mullen MD, Lane TA, Law P (2004) Retention of cellular properties of PBPCs following liquid storage and cryopreservation. Transfusion 44:245–52
Limaye LS, Kale VP (2001) Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium. J Hematother Stem Cell Res 10:709–18
Allan DS, Keeney M, Howson-Jan K et al (2002) Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 29:967–72
Beck C, Nguyen XD, Kluter H, Eichler H (2003) Effect of recombinant human deoxyribonuclease on the expression of cell adhesion molecules of thawed and processed cord blood hematopoietic progenitors. Eur J Haematol 70:136–42
Beaujean F, Hartmann O, Kuentz M, Le Forister C, Divine M, Duedari N (1991) A simple efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 8:291–4
Makino S, Harada M, Akashik K, Taniguchi S, Shibuya T, Inaba S et al (1991) A simlified method for cryopreservacion of PBSC at −80°C without rate-controlled freezing. Bone Marrow Transplant 8:239–44
Halle P, Tournilhac O, Knopinska-Posluszny W et al (2001) Uncontrolled-rate freezing and storage at −80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 41:579–80
Marjanović S, Balint B, Stamatović D, Obradović S (1998) Early treatment of extragonadal non-seminal germ cell tumor with high-doses chemotherapy support with autologous hematopoietic progenitor cell transplantation. Arch Oncology 6:135–6
Stamatovic D, Balint B, Todoric B, Marjanovic S, Lakic-Trajkovc Z, Malesevic M (2000) Secondary allogeneic bone marrow transplantation in the patient with severe aplastic anemia following late graft rejection. Vojnosanit Pregl 57(5 Suppl):95–8
Sauer-Heilborn A, Kadidlo D, McCullough J (2004) Patient care during infusion of hematopoietic progenitor cells. Transfusion 44(6):907–16
Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S (2004) The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 10:135–41
Balint B (2004) Stem cells—unselected or selected, unfrozen or cryopreserved: marrow repopulation capacity and plasticity potential in experimental and clinical settings. Macedonia Maked Med Pregl 58(Suppl 63):22–4
Spurr EE, Wiggins NE, Marsden KA, Lowenthal RM, Ragg SJ (2002) Cryopreserved human hematopoietic stem cells retain engraftment potential after extended (5–14 years) cryostorage. Cryobiology 44(3):210–7
Abrahamsen JF, Rusten L, Bakken AM, Bruserud O (2004) Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion 44:785–9
Balint B, Stamatovic D, Todorovic M, Jevtic M, Ostojic G, Pavlovic M et al (2007) Stem cells in the arrangement of bone marrow repopulation and regenerative medicine. Vojnosanit Pregl 64(7):481–4
Balint B, Todorovic M, Jevtic M, Ostojic G, Ristanovic E, Vojvodic D et al (2009) The use of stem cells for marrow repopulation and in the field of regenerative medicine. Maked Med Pregl 63(Suppl 75):12–7
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 The Author(s)
About this chapter
Cite this chapter
Pavlovic, M., Balint, B. (2013). Principles and Practice of Stem Cell Cryopreservation. In: Stem Cells and Tissue Engineering. SpringerBriefs in Electrical and Computer Engineering. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5505-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5505-9_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5504-2
Online ISBN: 978-1-4614-5505-9
eBook Packages: EngineeringEngineering (R0)